Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 22, 2026 20:13 ET | Source: PTTOW!

PTTOW! Sports Summit Reveals How To Navigate $600 Billion Market Amid ROI Crisis

Photo courtesy of PTTOW! Sports NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- Seventy-six percent of marketing executives cannot measure return on investment from sports sponsorships, creating...
March 22, 2026 20:05 ET | Source: The Rosen Law Firm PA

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
March 22, 2026 20:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a...
March 22, 2026 19:55 ET | Source: The Rosen Law Firm PA

ROSEN, A RANKED AND LEADING FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July...
March 22, 2026 19:51 ET | Source: Apogee Therapeutics

Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026

SAN FRANCISCO and BOSTON, March 22, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for...
March 22, 2026 19:33 ET | Source: The Rosen Law Firm PA

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE

NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) between...
March 22, 2026 19:13 ET | Source: Perseus Mining Limited

Perseus Makes 9.9% Investment in Aurum Resources

Perth, March 23, 2026 (GLOBE NEWSWIRE) -- PERSEUS MAKES 9.9% INVESTMENT IN AURUM RESOURCES Perth, Western Australia/March 23, 2026/Perseus Mining Limited (ASX/TSX: PRU) (Perseus or the Company) is...
March 22, 2026 18:53 ET | Source: Accolad Technologies Inc.

Plateforme de reconnaissance RH : Accolad modernise les programmes de reconnaissance des années de service au Canada

Accolad lance sa plateforme de reconnaissance RH pour automatiser les programmes d’années de service et offrir des récompenses personnalisées.
March 22, 2026 18:53 ET | Source: Accolad Technologies Inc.

HR Recognition Platform: Accolad Modernizes Employee Years of Service Programs Across Canada

Accolad launches its HR recognition platform to automate years of service programs and deliver personalized service award gifts that boost engagement.
March 22, 2026 18:52 ET | Source: Accolad Technologies Inc.

HR Recognition Platform: Accolad Modernizes Employee Years of Service Programs Across Canada

Accolad launches its HR recognition platform to automate years of service programs and deliver personalized service award gifts that boost engagement.